Back to NTLA
STATE STREET CORP NTLA Position History
Intellia Therapeutics, Inc. • Healthcare
Quarters held
12
Latest value
$156.3M
Q2 2026
Peak value
$156.3M
First seen
Q4 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2023 | $144.4M |
| Q1 2024 | $126.5M |
| Q2 2024 | $97.6M |
| Q3 2024 | $105.7M |
| Q4 2024 | $60.7M |
| Q1 2025 | $32.1M |
| Q2 2025 | $37.9M |
| Q3 2025 | $85.8M |
| Q4 2025 | $57.7M |
| Q1 2026 | $88.7M |
| Q2 2026 | $156.3M |
| Q2 2026 | $156.3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $156.3M | 9.23M | — | — |
| Q2 2026 | $156.3M | 9.23M | — | — |
| Q1 2026 | $88.7M | 6.92M | — | — |
| Q4 2025 | $57.7M | 6.42M | — | — |
| Q3 2025 | $85.8M | 4.97M | — | — |
| Q2 2025 | $37.9M | 4.04M | — | — |
| Q1 2025 | $32.1M | 4.51M | — | — |
| Q4 2024 | $60.7M | 5.21M | — | — |
| Q3 2024 | $105.7M | 5.14M | — | — |
| Q2 2024 | $97.6M | 4.36M | — | — |
| Q1 2024 | $126.5M | 4.60M | — | — |
| Q4 2023 | $144.4M | 4.74M | — | — |